Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Federal Trade Commission
Fish and Richardson
Colorcon
Daiichi Sankyo
Accenture
Express Scripts

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074248

« Back to Dashboard

NDA 074248 describes CLOBETASOL PROPIONATE, which is a drug marketed by Ingenus Pharms Llc, Perrigo Israel, Fougera Pharms Inc, G And W Labs Inc, Lupin Ltd, Mylan Pharms Inc, Taro, Teva Pharms Usa, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Actavis Mid Atlantic, Glenmark Pharms, Zydus Pharms Usa Inc, Hi-tech Pharmacal, Macleods Pharms Ltd, Novel Labs Inc, Tolmar, Wockhardt Bio Ag, Akorn, Paddock Llc, and Novast Labs Ltd, and is included in forty-five NDAs. It is available from twenty-nine suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 074248
Tradename:CLOBETASOL PROPIONATE
Applicant:Taro
Ingredient:clobetasol propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 074248
Medical Subject Heading (MeSH) Categories for 074248
Suppliers and Packaging for NDA: 074248
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 074248 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1259 N 51672-1259-3
CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 074248 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1259 N 51672-1259-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Jul 12, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Dow
Chinese Patent Office
Johnson and Johnson
Deloitte
Queensland Health
Healthtrust
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.